TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)
Alexander Lauten(German Centre for Cardiovascular Research), Christian W. Hamm(Universitätsklinikum Gießen und Marburg), Karl‐Heinz Kück, Joachim Kötting(Hochschule Düsseldorf University of Applied Sciences), David Holzhey, Thomas Walther(University Hospital Frankfurt), Gerhard Schüler(Institut de Médecine de la Reproduction), Christof Veit(Justus-Liebig-Universität Gießen), Ralf Zahn(Klinikum Ludwigshafen), Till Neumann(University of Duisburg-Essen), Gerd Heusch(West German Heart and Vascular Center Essen), Friedhelm Beyersdorf, Rüdiger Lange(Deutsches Herzzentrum der Charité), Stefan Sack(München Klinik Schwabing), Hans R. Figulla(Jena University Hospital), Thomas Meinertz(Universität Hamburg), Andreas Beckmann(Klinik Niederrhein), Friedrich W. Mohr(Goethe University Frankfurt), Jochen Cremer(Christian-Albrechts-Universität zu Kiel), Michael Böhm(Saarland University), Armin Welz(University of Bonn), Helge Möllmann(Kerckhoff Klinik)
Cited by 109
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k